Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04782180 · ClinicalTrials.gov registry record · Phase 4
PrEP at a Syringe Services Program
A Phase 4 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
NCT04782180 is a Phase 4 study that has completed, run by University of Miami. The registered enrollment target is 90 participants.
The verdict
NCT04782180, a Phase 4 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to see if providing participants with pre-exposure prophylaxis (PrEP) medicine right away at the IDEA Exchange will help participants remain in HIV negative.
Interventions
- DRUG Descovy 200Mg 25Mg Tablet
- BEHAVIORAL PrEP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2024-11-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04782180
The ClinicalTrials.gov registry entry for NCT04782180 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Descovy 200Mg 25Mg Tablet is the first listed.
NCT04782180 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04782180 about?
NCT04782180 is a clinical study titled "PrEP at a Syringe Services Program". The purpose of this study is to see if providing participants with pre-exposure prophylaxis (PrEP) medicine right away at the IDEA Exchange will help participants remain in HIV negative.
What is the current status of trial NCT04782180?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2022-02-01. Estimated completion is 2024-11-11.
What interventions are being tested in trial NCT04782180?
The interventions under investigation include: Descovy 200Mg 25Mg Tablet (DRUG), PrEP (BEHAVIORAL).
Who is sponsoring clinical trial NCT04782180?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.